Abbonarsi

New staining method using methionyl-tRNA synthetase 1 antibody for brushing cytology of bile duct cancer - 26/07/20

Doi : 10.1016/j.gie.2019.12.017 
Sung Ill Jang, MD, PhD 1, Nam Hoon Kwon, PhD 2, Beom Jin Lim, MD, PhD 3, Ji Hae Nahm, MD, PhD 3, Joon Seong Park, MD, PhD 4, Chang Moo Kang, MD, PhD 5, So Ra Park, PhD 1, Su Yun Lee, SD 1, Beom Sik Kang, PhD 6, Sunghoon Kim, PhD 2, 7, Dong Ki Lee, MD, PhD 1,
1 Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea 
3 Department of Pathology, Yonsei University College of Medicine, Seoul, Korea 
4 Department of Surgery, Yonsei University College of Medicine, Seoul, Korea 
5 Gangnam Severance Hospital and Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea 
2 Medicinal Bioconvergence Research Center, Seoul National University, Suwon, Gyeonggi-do, Korea 
7 Department of Molecular Medicine and Biopharmaceutical Sciences, College of Pharmacy, Graduate School of Convergence Science and Technology, Seoul National University, Suwon, Gyeonggi-do, Korea 
6 School of Life Science and Biotechnology, Kyungpook National University, Daegu, Korea 

Reprint requests: Dong Ki Lee, MD, PhD, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, 712 Eonjuro, Gangnam-gu, Seoul, Korea, 135-720.Department of Internal MedicineGangnam Severance HospitalYonsei University College of Medicine712 EonjuroGangnam-guSeoulKorea135-720

Abstract

Background and Aims

Identifying malignant biliary strictures using endobiliary brushing cytology specimens is important for treatment decision-making and prognosis prediction. The sensitivity of brushing cytology specimens based on Papanicolaou (Pap) staining is low, which hampers accurate diagnosis of indeterminate strictures. Here, we assessed the diagnostic value of immunohistochemical (IHC) and immunofluorescence (IF) staining for methionyl-tRNA synthetase 1 (MARS1).

Methods

Endobiliary brushing cytology specimens were obtained during ERCP from 80 patients with an extrahepatic biliary stricture. Pap and MARS1 IF staining were performed on liquid-based cytology slides derived from these specimens. Sections of bile duct adenocarcinoma and normal bile duct tissue were obtained from 45 patients who underwent surgery for malignant biliary stricture, and MARS1 levels were evaluated by IHC staining.

Results

MARS1 IF staining was applied to brushing cytology specimens, and the results showed strong signals in malignant biliary structures but not in the negative for malignancy specimens. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were 70.4%, 96.2%, 97.4%, 56.8%, and 78.8%, respectively, for conventional Pap staining and 98.1%, 96.1%, 98.1%, 96.2%, and 97.5%, respectively, for MARS1 IF (P < .0001). When IHC staining was used, MARS1 was detected in 45 bile duct adenocarcinoma sections but not in 15 normal bile duct sections. Moreover, MARS1 mRNA and protein levels were significantly higher in bile duct adenocarcinoma sections according to polymerase chain reaction and Western blot, respectively.

Conclusions

The high sensitivity and accuracy of MARS1 IF staining enabled detection of malignancy in patients with indeterminate biliary stricture. Further prospective studies are needed to validate our findings. (Clinical trial registration number: KCT 0003285.)

Il testo completo di questo articolo è disponibile in PDF.

Graphical abstract




Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : CCM, IF, IHC, MRI, MARS1, NPV, Pap, PPV, tRNA


Mappa


 DISCLOSURE: The following authors disclosed financial relationships: S. I. Jang, N. H. Kwon, B. J. Lim, S. Kim, D. K. Lee: Financial interests in Oncotag Diagnostics. All other authors disclosed no financial relationships. Oncotag Diagnostics had no role in the design and conduct of this study; the collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.
 If you would like to chat with an author of this article, you may contact Dr Lee at dklee@yuhs.ac.


© 2020  American Society for Gastrointestinal Endoscopy. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 92 - N° 2

P. 310 - agosto 2020 Ritorno al numero
Articolo precedente Articolo precedente
  • Propofol and lidocaine for ERCP: Two is better than one?
  • Sven Adamsen, John J. Vargo
| Articolo seguente Articolo seguente
  • Evaluation of indeterminate biliary strictures: Is there life on MARS?
  • Aatur D. Singhi, Adam Slivka

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.